Table 5 3-Month outcomes and safety of ICP monitoring
ICP monitoring, n = 90 | None-ICP monitoring, n = 61 | P value | |
|---|---|---|---|
Progressive intracranial hemorrhage (n, %) | |||
Hematoma enlargement | 13 (14.4) | 6 (9.8) | 0.462 |
New hemorrhagic lesion | 7 (7.8) | 4 (6.6) | 0.999 |
Operations plans | |||
Pre-operative scheduled bilateral DC | 33 (36.7) | 24 (39.3) | 0.864 |
Intraoperative scheduled contralateral DC | 20 (22.2) | 12 (19.8) | 0.839 |
Post-operative immediately contralateral DC | 18 (20.0) | 0 (0) | < 0.001 |
USS, (n, %) | 19 (21.1) | 25 (40.9) | 0.011* |
Length of ICU stay | 9 (6–17) | 13 (8–22) | 0.057 |
Complications and adverse events (n, %)# | |||
Hydrocephalus | 15 (16.7) | 13 (21.3) | 0.525 |
CNS Infection | 6 (6.7) | 3 (4.9) | 0.740 |
Others | 12 (13.3) | 6 (9.8) | 0.213 |
Modified Rankin Scale at 90 days (n, %) | 0.448 | ||
0: No symptoms at all | 1 (1.1) | 1 (1.6) | |
1: No substantive disability despite symptoms | 5 (5.5) | 1 (1.6) | |
2: Slight disability | 7 (7.6) | 4 (6.5) | |
3: Moderate disability requiring some help | 22 (24.1) | 3 (4.9) | |
4: Moderate–severe disability requiring assistance with daily living | 28 (30.7) | 16 (26.4) | |
5: Severe disability, bedbound and incontinent | 19 (20.2) | 21 (34.4) | |
6: Death by 90 days (mortality) | 8 (8.8) | 15 (24.6) | 0.0104* |